325 related articles for article (PubMed ID: 15454488)
1. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.
Balandina A; Lécart S; Dartevelle P; Saoudi A; Berrih-Aknin S
Blood; 2005 Jan; 105(2):735-41. PubMed ID: 15454488
[TBL] [Abstract][Full Text] [Related]
2. Analysis of CD4+CD25+ cell population in the thymus from myasthenia gravis patients.
Balandina A; Saoudi A; Dartevelle P; Berrih-Aknin S
Ann N Y Acad Sci; 2003 Sep; 998():275-7. PubMed ID: 14592885
[TBL] [Abstract][Full Text] [Related]
3. CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses.
Wing K; Larsson P; Sandström K; Lundin SB; Suri-Payer E; Rudin A
Immunology; 2005 Aug; 115(4):516-25. PubMed ID: 16011520
[TBL] [Abstract][Full Text] [Related]
4. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
[TBL] [Abstract][Full Text] [Related]
5. Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.
Xu WH; Zhang AM; Ren MS; Zhang XD; Wang F; Xu XC; Li Q; Wang J; Din BS; Wu YB; Chen GH
J Clin Immunol; 2012 Oct; 32(5):975-83. PubMed ID: 22467037
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects.
Truffault F; Nazzal D; Verdier J; Gradolatto A; Fadel E; Roussin R; Eymard B; Le Panse R; Berrih-Aknin S
Front Immunol; 2020; 11():782. PubMed ID: 32435245
[TBL] [Abstract][Full Text] [Related]
7. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody.
Moulian N; Bidault J; Truffault F; Yamamoto AM; Levasseur P; Berrih-Aknin S
Blood; 1997 May; 89(9):3287-95. PubMed ID: 9129034
[TBL] [Abstract][Full Text] [Related]
8. Undiminished regulatory T cells in the thymus of patients with myasthenia gravis.
Matsui N; Nakane S; Saito F; Ohigashi I; Nakagawa Y; Kurobe H; Takizawa H; Mitsui T; Kondo K; Kitagawa T; Takahama Y; Kaji R
Neurology; 2010 Mar; 74(10):816-20. PubMed ID: 20211905
[TBL] [Abstract][Full Text] [Related]
9. Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP.
Jiang Q; Su H; Knudsen G; Helms W; Su L
BMC Immunol; 2006 Apr; 7():6. PubMed ID: 16579866
[TBL] [Abstract][Full Text] [Related]
10. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
[TBL] [Abstract][Full Text] [Related]
11. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.
Watanabe N; Wang YH; Lee HK; Ito T; Wang YH; Cao W; Liu YJ
Nature; 2005 Aug; 436(7054):1181-5. PubMed ID: 16121185
[TBL] [Abstract][Full Text] [Related]
12. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.
Setoguchi R; Hori S; Takahashi T; Sakaguchi S
J Exp Med; 2005 Mar; 201(5):723-35. PubMed ID: 15753206
[TBL] [Abstract][Full Text] [Related]
13. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
[TBL] [Abstract][Full Text] [Related]
14. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
Stephens LA; Mottet C; Mason D; Powrie F
Eur J Immunol; 2001 Apr; 31(4):1247-54. PubMed ID: 11298351
[TBL] [Abstract][Full Text] [Related]
15. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
Luther C; Poeschel S; Varga M; Melms A; Tolosa E
J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
[TBL] [Abstract][Full Text] [Related]
16. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Fontenot JD; Gavin MA; Rudensky AY
Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
[TBL] [Abstract][Full Text] [Related]
17. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy.
Huang YM; Pirskanen R; Giscombe R; Link H; Lefvert AK
Scand J Immunol; 2004 Apr; 59(4):408-14. PubMed ID: 15049785
[TBL] [Abstract][Full Text] [Related]
19. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics.
Alahgholi-Hajibehzad M; Kasapoglu P; Jafari R; Rezaei N
Expert Rev Clin Immunol; 2015; 11(7):859-70. PubMed ID: 25973691
[TBL] [Abstract][Full Text] [Related]
20. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
